Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2026. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 35.1B USD
- Positions
- 90
- Share of the ten largest
- 35.7%
The ten largest positions Q2 2026
- Visa Inc. 6.3%▲ +1.0%
- Taiwan Semiconductor Manufacturing (ADR) 4.3%▼ −29.0%
- Air Products 4.0%▲ +15.5%
- Sherwin-Williams 3.8%▲ +24.5%
- Fortive 3.5%▼ −11.3%
- Meta Platforms 3.0%▲ +75.8%
- Charles Schwab Corporation 2.8%▼ −27.5%
- Thermo Fisher Scientific 2.8%▲ +16.2%
- JPMorgan Chase 2.7%▲ +7.2%
- Lennox International 2.6%▲ +1.2%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2026
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| V Visa Inc. | 6.3% | 6,393,604 | 2.2B USD | +1.0% increased | Q3 2024 8 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | 4.3% | 3,168,097 | 1.5B USD | −29.0% reduced | Q4 2024 7 quarters |
| APD Air Products | 4.0% | 4,740,351 | 1.4B USD | +15.5% increased | Q2 2025 5 quarters |
| SHW Sherwin-Williams | 3.8% | 3,875,879 | 1.3B USD | +24.5% increased | Q2 2024 9 quarters |
| FTV Fortive | 3.5% | 19,934,762 | 1.2B USD | −11.3% reduced | Q3 2019 28 quarters |
| META Meta Platforms | 3.0% | 1,867,619 | 1.1B USD | +75.8% increased | Q1 2026 2 quarters |
| SCHW Charles Schwab Corporation | 2.8% | 10,638,869 | 981.6M USD | −27.5% reduced | Q3 2024 8 quarters |
| TMO Thermo Fisher Scientific | 2.8% | 1,937,415 | 971.3M USD | +16.2% increased | Q4 2025 3 quarters |
| JPM JPMorgan Chase | 2.7% | 2,899,386 | 949.1M USD | +7.2% increased | Q2 2024 9 quarters |
| LII Lennox International | 2.6% | 1,590,959 | 911.5M USD | +1.2% increased | Q4 2025 3 quarters |
| AMZN Amazon | 2.5% | 3,700,862 | 882.1M USD | +209.6% increased | Q4 2025 3 quarters |
| Ferrari N V | 2.3% | 2,204,309 | 816.9M USD | new | Q2 2026 1 quarter |
| CVNA Carvana | 2.3% | 12,322,311 | 811.1M USD | −11.4% reducedafter 5:1 stock split | Q2 2024 9 quarters |
| Mcdonalds Corp | 2.2% | 2,829,158 | 764.7M USD | −22.0% reduced | Q1 2025 6 quarters |
| Bridgebio Pharma Inc | 2.1% | 9,949,219 | 741.0M USD | −16.0% reduced | Q2 2019 29 quarters |
| BA Boeing | 2.0% | 3,274,825 | 708.9M USD | +2.5% increased | Q4 2024 7 quarters |
| MAA Mid-America Apartment Communities | 2.0% | 5,043,318 | 700.7M USD | +5.1% increased | Q3 2025 4 quarters |
| DIS Walt Disney Company (The) | 2.0% | 7,158,406 | 689.0M USD | −46.2% reduced | Q2 2025 5 quarters |
| FDX FedEx | 1.9% | 2,151,983 | 673.9M USD | +11.4% increased | Q1 2026 2 quarters |
| MSCI MSCI | 1.9% | 1,160,687 | 650.0M USD | new | Q2 2026 1 quarter |
| Adaptive Biotechnologies Cor | 1.8% | 29,993,708 | 643.4M USD | unchanged | Q2 2019 29 quarters |
| WAT Waters Corporation | 1.8% | 1,662,140 | 623.4M USD | +32.3% increased | Q1 2026 2 quarters |
| JCI Johnson Controls | 1.8% | 4,202,694 | 614.1M USD | −4.9% reduced | Q2 2025 5 quarters |
| UNP Union Pacific Corporation | 1.6% | 2,047,332 | 556.9M USD | new | Q2 2026 1 quarter |
| MSFT Microsoft | 1.6% | 1,458,618 | 544.1M USD | −36.8% reduced | Q3 2025 4 quarters |
| SE Sea Limited (ADR) | 1.5% | 5,669,877 | 543.3M USD | +19.7% increased | Q1 2025 6 quarters |
| CPT Camden Property Trust | 1.5% | 4,513,303 | 516.7M USD | −4.3% reduced | Q1 2024 10 quarters |
| Regal Rexnord Corporation | 1.4% | 2,101,759 | 500.6M USD | −33.1% reduced | Q4 2023 11 quarters |
| Biomarin Pharmaceutical Inc | 1.2% | 7,616,563 | 435.8M USD | +7.9% increased | Q4 2021 19 quarters |
| IBKR Interactive Brokers | 1.2% | 4,830,748 | 420.5M USD | +246.5% increased | Q1 2026 2 quarters |
| DLR Digital Realty | 1.2% | 2,310,475 | 414.9M USD | new | Q2 2026 1 quarter |
| CCL Carnival Corporation | 1.2% | 14,299,953 | 408.5M USD | +4.2% increased | Q4 2025 3 quarters |
| GM General Motors | 1.1% | 5,005,833 | 385.8M USD | −45.5% reduced | Q4 2024 7 quarters |
| AON Aon plc | 1.1% | 1,151,269 | 381.9M USD | +5.9% increased | Q3 2025 4 quarters |
| CVS CVS Health | 1.1% | 3,663,361 | 379.0M USD | new | Q2 2026 1 quarter |
| Fedex Fght Hldg Co Inc | 1.0% | 2,366,634 | 357.4M USD | new | Q2 2026 1 quarter |
| ICE Intercontinental Exchange | 1.0% | 2,777,138 | 341.9M USD | −42.6% reduced | Q4 2025 3 quarters |
| MS Morgan Stanley | 1.0% | 1,622,593 | 339.2M USD | new | Q2 2026 1 quarter |
| HD Home Depot (The) | 0.9% | 920,595 | 324.7M USD | +82.6% increased | Q1 2026 2 quarters |
| Tic Solutions Inc | 0.8% | 35,824,562 | 289.8M USD | unchanged | Q1 2025 6 quarters |
| QCOM Qualcomm | 0.8% | 1,514,185 | 279.8M USD | new | Q2 2026 1 quarter |
| APTV Aptiv | 0.8% | 4,552,887 | 279.5M USD | new | Q2 2026 1 quarter |
| RDDT Reddit | 0.8% | 1,565,518 | 271.7M USD | −38.6% reduced | Q1 2026 2 quarters |
| HAS Hasbro | 0.7% | 3,107,195 | 256.6M USD | −16.9% reduced | Q1 2026 2 quarters |
| Avalonbay Cmntys Inc | 0.7% | 1,339,782 | 252.8M USD | new | Q2 2026 1 quarter |
| Dicks Sporting Goods Inc | 0.7% | 1,106,134 | 250.9M USD | −12.5% reduced | Q4 2025 3 quarters |
| SNOW Snowflake | 0.7% | 960,138 | 244.4M USD | new | Q2 2026 1 quarter |
| Equitable HLDGS Inc | 0.7% | 5,398,896 | 236.9M USD | new | Q2 2026 1 quarter |
| TTWO Take-Two Interactive | 0.7% | 940,605 | 235.1M USD | new | Q2 2026 1 quarter |
| TSLA Tesla, Inc. | 0.7% | 547,816 | 230.4M USD | −78.0% reduced | Q1 2025 6 quarters |
| Ati Inc | 0.6% | 1,153,880 | 227.4M USD | −65.4% reduced | Q1 2026 2 quarters |
| Roivant Sciences Ltd | 0.6% | 6,271,467 | 221.9M USD | −5.7% reduced | Q4 2021 19 quarters |
| SPCX Space Exploration Technologies (Class A) | 0.6% | 1,200,000 | 205.0M USD | new | Q2 2026 1 quarter |
| Amer Sports Inc | 0.6% | 5,954,351 | 201.5M USD | −18.1% reduced | Q1 2025 6 quarters |
| Veradermics Inc | 0.5% | 1,561,494 | 192.0M USD | −7.6% reduced | Q1 2026 2 quarters |
| Medline Inc | 0.5% | 4,841,080 | 190.9M USD | −57.7% reduced | Q4 2025 3 quarters |
| Bce Inc | 0.5% | 8,383,278 | 180.6M USD | new | Q2 2026 1 quarter |
| US Foods Hldg Corp | 0.5% | 1,734,346 | 177.3M USD | new | Q2 2026 1 quarter |
| Oruka Therapeutics Inc | 0.4% | 1,503,478 | 143.1M USD | – | Q3 2025 4 quarters |
| Newamsterdam Pharma Company | 0.4% | 4,203,567 | 142.5M USD | unchanged | Q4 2022 15 quarters |
| Sionna Therapeutics Inc | 0.4% | 3,195,181 | 140.6M USD | unchanged | Q1 2025 6 quarters |
| CB Chubb Limited | 0.4% | 377,312 | 128.6M USD | −70.9% reduced | Q4 2025 3 quarters |
| Pharvaris N V | 0.4% | 3,653,310 | 126.3M USD | unchanged | Q1 2021 22 quarters |
| UBS Group AG | 0.3% | 2,435,805 | 120.8M USD | new | Q2 2026 1 quarter |
| Brightspring Health Svcs Inc | 0.3% | 1,618,237 | 112.9M USD | new | Q2 2026 1 quarter |
| Inhibrx Biosciences Inc | 0.3% | 1,123,929 | 106.5M USD | −21.8% reduced | Q2 2024 9 quarters |
| Natera Inc | 0.3% | 390,694 | 106.1M USD | new | Q2 2026 1 quarter |
| Deutsche Bk AG | 0.2% | 2,510,554 | 85.0M USD | new | Q2 2026 1 quarter |
| COF Capital One | 0.2% | 387,815 | 77.8M USD | −75.9% reduced | Q1 2025 6 quarters |
| Corebridge Finl Inc | 0.2% | 2,679,371 | 76.7M USD | new | Q2 2026 1 quarter |
| Solaredge Technologies Inc | 0.2% | 1,088,469 | 63.6M USD | new | Q2 2026 1 quarter |
| Damora Therapeutics Inc | 0.2% | 2,311,082 | 60.1M USD | unchanged | Q1 2026 2 quarters |
| Oric Pharmaceuticals Inc | 0.2% | 5,126,762 | 55.5M USD | −12.0% reduced | Q1 2024 10 quarters |
| Bruker Corp | 0.2% | 893,491 | 53.8M USD | new | Q2 2026 1 quarter |
| Standard Biotools Inc | 0.1% | 58,651,170 | 48.3M USD | unchanged | Q1 2024 10 quarters |
| Ginkgo Bioworks Holdings Inc | 0.1% | 3,577,128 | 35.4M USD | unchanged | Q3 2024 8 quarters |
| CME CME Group | < 0.1% | 152,980 | 33.8M USD | new | Q2 2026 1 quarter |
| Tradeweb Mkts Inc | < 0.1% | 314,222 | 31.3M USD | new | Q2 2026 1 quarter |
| Trevi Therapeutics Inc | < 0.1% | 1,544,644 | 28.8M USD | −51.7% reduced | Q3 2022 16 quarters |
| Infleqtion Inc | < 0.1% | 2,032,649 | 27.1M USD | new | Q2 2026 1 quarter |
| Artiva Biotherapeutics Inc | < 0.1% | 2,604,166 | 25.3M USD | new | Q2 2026 1 quarter |
| Quantinuum Inc | < 0.1% | 306,123 | 25.0M USD | new | Q2 2026 1 quarter |
| Fervo Energy Co | < 0.1% | 750,000 | 21.9M USD | new | Q2 2026 1 quarter |
| Altimmune Inc | < 0.1% | 6,700,000 | 20.4M USD | new | Q2 2026 1 quarter |
| Toll Brothers Inc | < 0.1% | 109,856 | 18.1M USD | new | Q2 2026 1 quarter |
| Dpc Holdings PLC | < 0.1% | 306,123 | 15.0M USD | new | Q2 2026 1 quarter |
| X-Energy Inc | < 0.1% | 714,286 | 13.1M USD | new | Q2 2026 1 quarter |
| Azul S A | < 0.1% | 1,349,734 | 12.1M USD | new | Q2 2026 1 quarter |
| Rallybio Corp | < 0.1% | 524,347 | 8.4M USD | unchanged | Q1 2026 2 quarters |
| Pepgen Inc | < 0.1% | 3,482,434 | 6.3M USD | unchanged | Q2 2022 17 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Financials 18.5%
- Industrials 13.3%
- Consumer Discretionary 10.2%
- Materials 7.8%
- Technology 7.4%
- Communication Services 6.4%
- Health Care 5.6%
- Real Estate 4.7%
- not in our coverage 26.1%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors